Officer and Director Stock Transactions

Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc. (BCAX), executed several transactions on March 16, 2026, under a Rule 10b5-1 trading plan. He acquired 8,000 shares of Common Stock at a price of $3.7898 per share, increasing his direct holdings to 213,141 shares. Subsequently, he disposed of 8,000 shares at a weighted average price of $19.6571, with individual sales ranging from $19.34 to $19.96, leaving him with 205,141 shares. Additionally, he disposed of another 4,500 shares at the same weighted average price, reducing his holdings to 200,641 shares. In a related derivative transaction, Cohlhepp disposed of a stock option (right to buy) for 8,000 shares of Common Stock, which were acquired at an exercise price of $3.7898. Following these transactions, his direct ownership of stock options stands at 117,334 shares.